Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

BioFire Blood Culture Identification 2 (BCID2) Panel

K-Number: K193519 · 2020-03-18

Decision Date2020-03-18
Product CodePEN
Advisory CommitteeMI
DecisionSubstantially Equivalent

Device Summary

BioFire Blood Culture Identification 2 (BCID2) Panel is a medical device manufactured by Biofire Diagnostics, LLC. It received FDA 510(k) clearance on 2020-03-18 under approval number K193519. The device is classified under product code PEN. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the BioFire Blood Culture Identification 2 (BCID2) Panel?

BioFire Blood Culture Identification 2 (BCID2) Panel is a medical device that received FDA 510(k) clearance on 2020-03-18. It is manufactured by Biofire Diagnostics, LLC. The 510(k) number is K193519.

When was BioFire Blood Culture Identification 2 (BCID2) Panel approved by the FDA?

BioFire Blood Culture Identification 2 (BCID2) Panel received FDA 510(k) clearance on 2020-03-18, under approval number K193519.

What company makes BioFire Blood Culture Identification 2 (BCID2) Panel?

BioFire Blood Culture Identification 2 (BCID2) Panel is manufactured by Biofire Diagnostics, LLC.

What is the FDA product code for BioFire Blood Culture Identification 2 (BCID2) Panel?

The FDA product code for BioFire Blood Culture Identification 2 (BCID2) Panel is PEN.

Related Clinical Trials

Other Devices by Biofire Diagnostics, LLC

View all 23 devices →

Related Devices (Code: PEN)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.